the volume of tissue affected by interstitial edema increases. Over time, when absorption exceeds the extravasation of plasma ultrafiltrate, surrounding tissue will swell due to its subjection to solid stresses (stretching) that favor cyst formation. 24, 27, 32 This process results in the formation of a peritumoral cyst. Formation of the cyst alters interstitial flow patterns so that the majority of excess interstitial fluid channels into the peritumoral cyst, given that it is the pathway of least flow resistance. 28, 32 We describe the clinical, neuroimaging, histological, and molecular evidence that underlies this mechanism of peritumoral cyst formation.
Peritumoral Edema Underlies Peritumoral Cyst Formation
Neuroimaging Evidence. Consistent with the origination of peritumoral edema from highly permeable tumor vessels and an association between edema and peritumoral cyst formation, MR imaging and computed tomography study data have demonstrated that increased tumor vascular permeability is associated with increases in peritumoral edema, which in turn is associated with peritumoral cyst formation. Pronin and colleagues 39 and Holodny and associates 16 found that increased tumor vessel permeability, as demonstrated by increased enhancement on MR images, directly correlated with increasing peritumoral edema in gliomas. Lohle and coworkers 23 extended these findings and used MR imaging and computed tomography volumetric analysis (tumor, tissue edema, and peritumoral cyst volumes) to determine the relationship between tumorassociated edema and peritumoral cysts. Results of an analysis of 60 patients harboring either primary (30 patients) or metastatic (30 patients) brain neoplasms (half of the tumors had associated peritumoral cysts) revealed that lesions with a larger tumor/edema volume ratio were significantly more likely to have an associated peritumoral cyst, indicating a link between tumor-associated edema and peritumoral cyst formation.
Consistent with edema and cyst formation due to plasma extravasation from permeable tumor vessels, dynamic contrast-enhanced MR imaging studies have demonstrated leakage of intravenous contrast agent from primary CNS neoplasms into peritumoral tissues and/or peritumoral cysts. Because Gd-DTPA is a hydrophilic MR imaging contrast agent that remains exclusively within the CNS vasculature unless there is disruption of the blood-brain barrier, imaging evidence of agent extravasation is indicative of abnormal CNS vessel permeability. Bitzer and colleagues 5 prospectively performed delayed (0.6, 3.5, and 6.5 hours after Gd-DTPA injection) contrast-enhanced MR imaging studies in 28 patients with 32 meningiomas (12 without and 20 with associated peritumoral edema). Similar to findings of abnormal tumor vascular permeability underlying the formation of edema, they found significant contrast effusion (into the surrounding peritumoral tissue) from lesions with associated edema but not from those without edema. Relatedly, Lonser et al. 28, 32 analyzed contrast-enhanced MR imaging data obtained in 17 patients with 23 CNS hemangioblastomas that had associated edema and peritumoral cysts/syrinxes. They found that Gd-DTPA rapidly extravasates from highly permeable tumor vessels into not only surrounding edematous tissue, but also preferentially into peritumoral cysts (Fig. 1) .
Most recently, long-term longitudinal MR imaging studies have directly demonstrated the pathological mechanisms and natural history of peritumoral cyst formation associated with CNS hemangioblastomas. Lonser and associates 32 performed serial MR imaging (T1-weighted with contrast and T2-weighted) in 22 patients with von Hippel-Lindau syndrome and demonstrated that hemangioblastoma-associated peritumoral edema progressed into peritumoral cysts (Figs. 2 and 3 ) over a period of several years (mean time from edema development to peritumoral cyst formation, 3 years; range 8-72 months). All peritumoral cysts were preceded by edema formation. These authors found that the peritumoral cysts grew significantly faster than the associated hemangioblastoma, indicating that tumor growth is not a necessary feature of peritumoral cyst formation. Moreover, the mass effect from these peritumoral cysts, not the underlying hemangioblastomas, was the cause of clinical symptoms in the patients.
Tumor Vessel Permeability. The intratumoral expression of VEGF 4, 8, 44, 51 by a variety of neoplasms has been positively correlated with the presence of edema and cysts and has been implicated as a factor that mediates the develop- ment of peritumoral edema and cysts. 12, 52 Previously, it had been hypothesized that the association of VEGF expression with peritumoral edema and cysts was a result of VEGF's potent angiogenic and permeability-inducing actions on immediately surrounding tissue and vessels. However, a recent analysis 47, 50, 57 of VEGF concentrations in the peritumoral cyst fluid of astrocytomas and hemangioblastomas revealed that intracystic VEGF levels were far below (often more than an order of magnitude less) those necessary to cause increased permeability in cerebral 55 or cutaneous 13 endothelial cells. In fact, some of these fluids had VEGF concentrations that were no higher than those in normal serum or plasma. These findings indicated that tumor vessels, which are in direct contact with the VEGF-producing stromal cells and are clearly abnormal/proliferative, are more susceptible to VEGF-induced leakiness than are vessels in the normal brain adjacent to the cyst, which are normal in appearance and exposed to only low concentrations of VEGF. Consistent with increased tumor vascular permeability driven by a VEGF-derived mechanism (through the overexpression of, or abnormal, VEGF receptors and/or increased tumor VEGF expression), Batchelor et al. 3 found that the abnormal permeability of GBM tumor vessels normalized after systemic treatment with a pan-VEGF receptor inhibitor (AZD2171). These results lend further support to a process of peritumoral cyst formation and growth that is driven by the lesion itself.
Peritumoral Cyst Fluid Analysis. To confirm that peritumoral cyst fluid is derived from plasma extravasation through permeable tumor vessels, authors of a number of studies have characterized peritumoral cyst fluid proteins. 11, 24, 25, 32 These authors have demonstrated that peritumoral cyst fluid from gliomas, metastases, and other CNS tumors have a spectrum of proteins nearly identical to those found in serum plasma, indicating that a plasma ultrafiltrate is the source of edema and peritumoral cyst fluid. 26, 27 Lohle and associates 24 investigated peritumoral cyst fluid from 22 patients with cerebral gliomas and found that 92% of the cyst fluid consisted of the plasma protein fraction. Later, Lohle et al. 25 analyzed 39 cyst fluid samples from patients with primary and metastatic tumors and confirmed that 86% of the proteins in these cysts were plasma proteins. Most recently, Lonser et al. 32 and Glasker et al. 11 performed 2D gel electrophoresis on hemangioblastoma peritumoral cyst fluid and found that the proteomic pattern of the cyst fluid and serum was similar among patients, indicating that the cyst fluid originated from a plasma ultrafiltrate through permeable vessels.
Hydrodynamic Forces. The rapid extravasation and interstitial spread (much greater and faster than would be expected if driven by diffusional forces alone) of Gd-DPTA on MR imaging 5, 28, 32 into regions of peritumoral edema and cysts suggests that vascular leakiness alone may not be sufficient for the significant development of edema and peritumoral cysts. Rather, it appears that pulsatile forces (hydrodynamic) combined with vascular leakiness may underlie widespread edema formation and peritumoral cyst formation. 32 In 1984 Rennels et al. 42 reported that horseradish peroxidase rapidly moves into the CNS parenchyma from the CSF and that this rapid movement occurs only if the normal pulsatile pressure waves in the CSF are present. In 1994, Oldfield et al. 37 proposed that exaggerated pulse pressure in the spinal subarachnoid space associated with partial entrapment of the spinal CSF in patients with a Chiari malformation Type I was the driving force underlying the development of syringomyelia. In 1996 Stoodley et al. 48 confirmed the observations of Rennels et al. 42 and demonstrated that the bulk flow move-
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From edema to cyst formation 14 in 1999. This series of observations supports a hypothesis that arterially-derived pulsations can enhance the movement of bulk flow into the CNS parenchyma and that under these conditions the excess extracellular fluid (seen as edema on MR images) can coalesce into a cystic cavity in the spinal cord and brain. 32, 34, 37, 53, 56 
Clinical Implications

Predictors of Cyst Formation and Propagation
The formation of peritumoral edema is indicative of possible peritumoral cyst formation. The accumulation of increased interstitial fluid (edema) occurs because the rate of fluid formation exceeds the rate of fluid removal. With progressive edema and arterial-driven pulsations, excess fluid generated by the lesion is distributed into surrounding tissue, creating an increase in interstitial pressure. 5, 17, 32 As the surrounding tissue swells, it is subject to solid stresses (stretching) that favor cyst formation. Interstitial flow patterns probably change once a cyst forms, with the majority of excess interstitial fluid channeling into the adjacent cyst, given that this pathway provides the least flow resistance. 32 Initial accommodations to a change in this flow pattern can account for the initial rapid increases in cyst volume that have been observed (Figs. 2 and  3) . 32 Two physiological processes can also serve to stabilize cyst volume. First, as the cyst increases in size, its resorptive surface area increases its capacity to resorb excess fluid formation. Second, compression of adjacent parenchyma increases the interstitial pressure, directly opposing the hydrodynamic forces that drive fluid into the cyst.
Although the precise latency from edema to cyst formation cannot be determined, previous study data have indicated that it ranges from several months to several years. The long latency between edema formation and peritumoral cyst development may explain the relative lack of peritumoral cysts associated with very malignant CNS tumors (for example, GBM) compared with benign neoplasms (for example, hemangioblastomas). 24, 26, 32 Because malignant tumors grow rapidly and are associated with mass effect over a short time course (daysweeks), it is quite possible that treatment or death due to these neoplasms occurs before peritumoral cysts form. Alternatively, benign slow-growing lesions that have significant peritumoral edema can develop peritumoral cysts before discovery and subsequently are associated with a higher incidence.
Therapeutic Variables
Implications for Familial Neoplasia Syndromes. Neurofibromatosis, Li-Fraumeni cancer syndrome, tuberous sclerosis, and von Hippel-Lindau syndrome are some familial neoplasia conditions that have well-described associated CNS tumors that can develop peritumoral cysts. 15, 29, 35 Because associated peritumoral cysts can stop growing once the surface area of the sac is sufficiently large to resorb excess fluid extravasated from the tumor, they can become quiescent and potentially remain asymptomatic for long periods of time or even indefinitely. 29, 32, 53 Thus, neuroimaging-demonstrated development or growth of peritumoral cysts is not an absolute indication for tumor resection in the context of familial neoplasia syndromes in which multiple known CNS lesions arise (benign tumors with peritumoral cysts), and judicious surgical treatment is critical because of the multiplicity of tumors and the potential for multiple surgeries during a patient's lifetime.
Implications for Surgery. Because increased tumor vascular permeability underlies peritumoral edema and subsequent cyst formation, resolution of peritumoral edema and cysts will occur after removal of the tumor that underlies their formation. Subsequently, removal of the cyst wall or wide fenestration of the cyst is not necessary, 32, 56 and peritumoral edema and cyst resolution (or cyst collapse) should occur after complete resection of the associated tumor. Thus, postoperative imaging evidence of peritumoral cyst propagation may be associated with residual tumor or another unresected tumor. 34 Implications for Radiation. Animal and clinical study data have demonstrated that radiation at least transiently increases vascular permeability. 9, 21, 40, 41, 58, 59 Correspondingly, a number of authors have shown that after radiation of benign and malignant CNS tumors, there is an increase in peritumoral edema and de novo formation and/or propagation of peritumoral cysts. 7, 18, 36, 45, 46, 49, 54 The observation that increased vascular permeability leads to the initiation and propagation of peritumoral edema (and, ultimately, to cysts) can explain why increased edema and peritumoral cyst formation have been associated with radiation. These findings also suggest that caution should be used when irradiating tumors with significant peritumoral edema or cysts because radiation-induced increases in tumor vessel permeability could lead to clinical deterioration.
Implications for Chemotherapy. Based on a process of peritumoral cyst formation that depends on increased tumor vascular permeability, chemotherapeutic agents that directly or indirectly decrease vascular permeability may have the benefit of reducing edema and/or peritumoral cyst formation, leading to improvement in edema-and/or cyst-related symptoms. Batchelor and colleagues 3 administered AZD2171, a potent oral pan-VEGF receptor tyrosine kinase inhibitor, to 16 patients with recurrent GBM. These authors demonstrated with MR imaging that tumor vascular permeability normalization occurred within 24 hours of administering the drug and lasted at least 28 days, resulting in a significant reduction in peritumoral edema. Moreover, Aiello et al. 2 and Girmens et al. 10 have described patients with von Hippel-Lindau syndrome and loss of visual acuity due to macular hemangioblastomas that were treated with SU5416, another VEGF tyrosine kinase inhibitor. Although the treatment failed to decrease the tumor size, it did reduce cystoid macular edema and therefore improved visual acuity. Similar chemotherapeutic management paradigms may be feasible in patients with tumors not amenable to resection or radiation therapy but in whom clinical signs and symptoms are attributable to edema or peritumoral cysts.
Implications for Convection-Enhanced Delivery. Previously, we and others have shown that convection-enhanced delivery can be used to bypass the blood-brain barrier to distribute small-and large-molecular-weight compounds within the CNS safely and homogeneously over a wide range of volumes. 6, 19, 20, 31, 38, 43 Substrate is delivered under continuous pressure using bulk flow to drive solute through the interstitial space. Because the infusate is driven by a pressure gradient, convection-enhanced delivery increases the interstitial fluid content in the region of infusion and expands the interstitial space (edema) by the delivery of fluid at rates that can exceed the absorptive capacity of the tissue. Although we have not seen irreversible neurological deficits or significant elevations in intracranial pressure related to an increase in interstitial fluid with convective delivery in small animals, 6, 22 nonhuman primates, 30, 33 or humans, 20, 31 it is conceivable that sustained interstitial delivery of infusate can create a situation in which delivery overwhelms the tissue's absorptive capacity, leading to edema formation and to subsequent cyst development. Thus, an interstitial infusion delivered over an extended interval, as might be necessary for the successful delivery of neurotrophic factors, could lead to cyst formation. In that circumstance, the cessation of, a rate reduction in, or the use of intermittent intervals of infusion should prevent or lead to resolution of edema, cysts, and symptoms.
Conclusions
Edema is a common precursor to peritumoral cyst formation in the CNS. The mechanism of cyst formation in patients with CNS neoplasms appears to be the result of an interstitial process that starts with the generation of edema. Vascular permeability factors acting locally on abnormal tumor vasculature in conjunction with hydrodynamic forces drive fluid (plasma) extravasation. When these forces overcome the ability of the surrounding tissue to resorb fluid, edema (with its associated increased interstitial pressure) and subsequent cyst formation occur. Because the tumor itself, not the adjacent tissue, is the source of the edema that precedes cyst formation, tumor resection is sufficient to result in the resolution of edema and cysts by eliminating the underlying pathophysiological process. Similarly, chemotherapeutic management paradigms that reduce tumor vascular permeability may be helpful in patients with tumors not amenable to resection or radiation therapy, but in whom clinical signs and symptoms are attributable to edema or peritumoral cysts.
